Fund Holdings — Merck & Co., Inc.

Total Portfolio Value:
$276.28M
Total Bought:
$0
Total Sold:
$2.58M
Net Transaction:
-$2.58M
Securities
▲▼
SharesValue
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Personalis, Inc.(PSNL)14,044,94314,044,9430$91.57M$111.80M40.47%+$20.22M
Moderna, Inc.(MRNA)2,308,1902,308,1900$59.62M$68.07M24.64%+$8.45M
Kymera Therapeutics, Inc.(KYMR)772,165772,1650$43.70M$60.08M21.75%+$16.38M
Entrada Therapeutics, Inc.(TRDA)1,739,7681,739,7680$10.09M$17.88M6.47%+$7.79M
Evaxion Biotech A/sADS1,214,1261,214,1260$4.57M$5.79M2.10%+$1.23M
Alector Inc3,545,7193,545,7190$10.50M$5.53M2.00%-$4.96M
Sutro Biopharma, Inc.(STRO)2,723,509272,351-2,451,158$2.37M$3.15M1.14%+$786.0K
Viridian Therapeutics, Inc.(VRDN)93,41493,4140$2.02M$2.91M1.05%+$891.2K
Xilio Therapeutics, Inc.(XLO)1,483,7581,483,7580$1.25M$949.9K0.34%-$300.5K
Carisma Therapeutics Inc1,473,2401,473,2400$403.7K$63.3K0.02%-$340.3K
Neuphoria Therapeutics Inc10,02710,0270$118.2K$38.9K0.01%-$79.3K
TuHURA Biosciences, Inc.(HURA)13,95013,9500$34.6K$10.6K0.00%-$24.0K
Lava Therapeutics NvSHS1,149,3450-1,149,345$1.79M$0—-$1.79M
Page 1 of 1
Merck & Co., Inc. — 13F Holdings — Q4 2025 | TickerTrail